Acceleron in advanced talks for $11 billion sale - Bloomberg News - NewsBreak

(Reuters) - U.S. drugmaker Acceleron Pharma Inc is in advanced talks to be acquired by a large pharmaceutical company for more than $11 billion, Bloomberg News reported on Friday, citing people familiar with the matter. The acquisition would be made at about $180 per share in cash, the report said...